Panacea Biotec - Quaterly Results

14 Nov 2022 Evaluate
The sales for the September 2022 quarter moved down -59.13% to Rs. 487.40 millions as compared to Rs. 1192.60 millions during the year ago period.The Net Loss for the quarter ended September 2022 is Rs. -68.50 millions as compared to Net Loss of Rs. -223.70 millions of corresponding quarter ended September 2021 Operating profit Margin for the quarter ended September 2022 improved to 16.00% as compared to -139.80% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 487.40 1192.60 -59.13 1100.80 1555.20 -29.22 2355.00 3435.60 -31.45
Other Income 79.20 34.70 128.24 144.50 76.20 89.63 125.70 207.40 -39.39
PBIDT 16.00 -139.80 -111.44 -638.90 -292.40 118.50 -601.10 212.40 -383.00
Interest 22.10 19.10 15.71 46.80 36.90 26.83 70.40 75.20 -6.38
PBDT -6.10 -158.90 -96.16 -685.70 -329.30 108.23 -671.50 137.20 -589.43
Depreciation 62.40 64.80 -3.70 125.20 129.10 -3.02 264.30 265.70 -0.53
PBT -68.50 -223.70 -69.38 -810.90 -458.40 76.90 -935.80 -128.50 628.25
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.60 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -7.10 0.00
PAT -68.50 -223.70 -69.38 -810.90 -458.40 76.90 -935.80 -144.10 549.41
Equity 61.30 61.30 0.00 61.30 61.30 0.00 61.30 61.30 0.00
PBIDTM(%) 3.28 -11.72 -128.00 -58.04 -18.80 208.70 -25.52 6.18 -512.86

Panacea Biotec Share Price

407.05 48.55 (13.54%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×